💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
User | Tweets |
---|---|
@Allstocknews | 7 |
@FlashAlert_me | 6 |
@newsfilterio | 6 |
@MarcJacksonLA | 4 |
@TradeWithAlerts | 3 |
![]() |
@TradeWithAlerts Large Print $NBIX Size: 106088 Price: 94.85 Time: 1600 Amount: $10,062,446.80 April 19th 2021, 8:04pm |
![]() |
@stockhoot $NBIX Morgan Stanley Maintains to Overweight : PT $125.00 https://t.co/aoZbmPU9FY April 19th 2021, 2:04pm |
![]() |
@newsfilterio Form 3 (initial statement of beneficial ownership of securities) filed with the SEC $NBIX https://t.co/HAzdZwNoeZ April 17th 2021, 5:04am |
![]() |
@newsfilterio 17,180 shares acquired by Mercier Johanna (Director), reported in a new form 4 filed with the SEC $NBIX https://t.co/0HDa8lJoJc April 17th 2021, 5:04am |
![]() |
@InsiderAlerts4U $NBIX: New Insider Filing on NEUROCRINE BIOSCIENCES INC's Director JOHANNA MERCIER: https://t.co/Qs4nI7jOKb April 16th 2021, 8:04pm |
![]() |
@Allstocknews $NBIX New Form 3 for Neurocrine Biosciences, Inc. From our Stock News Alerts App April 16th 2021, 8:04pm |
![]() |
@FlashAlert_me $NBIX [15s. delayed] filed SEC form 4: Director Mercier Johanna: Transacted Derivative Securities on 2021-04-15. https://t.co/frmIKdIWp4 April 16th 2021, 8:04pm |
![]() |
@FlashAlert_me $NBIX [15s. delayed] filed SEC form 3: Director Mercier Johanna: https://t.co/iom9gZB1SF April 16th 2021, 8:04pm |
![]() |
@newsfilterio Neurocrine Biosciences Announces Appointment of Johanna Mercier to Board of Directors $NBIX https://t.co/Zg8zgBTAl1 April 16th 2021, 3:04pm |
![]() |
@MarcJacksonLA $NBIX Neurocrine Biosciences Appoints Johanna Mercier To Board of Directors https://t.co/MQm4JuDZ70 April 16th 2021, 1:04pm |
![]() |
@FlashAlert_me $NBIX [15s. delayed]: Issued Press Release on April 16, 09:00:00: Neurocrine Biosciences Announces Appointment of J… https://t.co/jzXK5FVig4 April 16th 2021, 1:04pm |
![]() |
@SwingTradeBot Recent $NBIX technical alerts: Non-ADX 1,2,3,4 Bearish plus 3 more alerts... https://t.co/zVcidEswK7 April 16th 2021, 1:04pm |
![]() |
@StockTexts $NBIX Neurocrine Biosciences, Inc. SEC Filing: Form 8-K https://t.co/I2hDrc2atb April 16th 2021, 1:04pm |
![]() |
@otcdynamics $NBIX Neurocrine Biosciences Announces Appointment of Johanna Mercier to Board of Directors https://t.co/psjx2rEz45 April 16th 2021, 1:04pm |
![]() |
@Allstocknews $NBIX New Form 8-K for Neurocrine Biosciences, Inc. From our Stock News Alerts App April 16th 2021, 1:04pm |
![]() |
@Allstocknews $NBIX Neurocrine Biosciences Announces Appointment of Johanna Mercier to Board of Directors From our Stock News Alerts App April 16th 2021, 1:04pm |
![]() |
@EdgarInsider FORM 8-K [Press/News Current Report] recently SEC filed. $NBIX NEUROCRINE BIOSCIENCES INC https://t.co/3Aegt7YcrN April 16th 2021, 1:04pm |
![]() |
@FlashAlert_me $NBIX [15s. delayed] filed form 8-K on April 16, 09:02:16: Item5.02: Departure of Election 0f Officers or Compensat… https://t.co/QBLUxZv7KX April 16th 2021, 1:04pm |
![]() |
@stock_titan $NBIX Neurocrine Biosciences Announces Appointment of Johanna Mercier to Board of Directors https://t.co/E4eAWVNRjw April 16th 2021, 1:04pm |
![]() |
@newsfilterio Neurocrine Biosciences Announces Conference Call and Webcast of First Quarter 2021 Financial Results $NBIX https://t.co/B9DUF6yPaK April 15th 2021, 1:04am |
![]() |
@Allstocknews $NBIX Neurocrine Biosciences Announces Conference Call and Webcast of First Quarter 2021 Financial Results From our Stock News Alerts App April 14th 2021, 9:04pm |
![]() |
@otcdynamics $NBIX Neurocrine Biosciences Announces Conference Call and Webcast of First Quarter 2021 Financial Results https://t.co/FJiHnYfO4z April 14th 2021, 8:04pm |
![]() |
@FlashAlert_me $NBIX [15s. delayed]: Issued Press Release on April 14, 16:01:00: Neurocrine Biosciences Announces Conference Call… https://t.co/n9qdqY63UV April 14th 2021, 8:04pm |
![]() |
@stock_titan $NBIX Neurocrine Biosciences Announces Conference Call and Webcast of First Quarter 2021 Financial Results https://t.co/sVyVG2ZudK April 14th 2021, 8:04pm |
![]() |
@MarcJacksonLA $NBIX Neurocrine Biosciences Stock Rating Upgraded by Zacks Investment Research To Buy From Hold, $105 PT… https://t.co/iy0PVu6c6x April 14th 2021, 3:04pm |
![]() |
@Gambiste1 RT @savage_swings: $NBIX #Earnings 5/4 EPS beat and near sales miss 2/4 Maintained outperform by Wedbush with a 112 PT. Appears to be at su… April 14th 2021, 2:04am |
![]() |
@savage_swings $NBIX #Earnings 5/4 EPS beat and near sales miss 2/4 Maintained outperform by Wedbush with a 112 PT. Appears to be… https://t.co/bcWsNSmqiy April 14th 2021, 1:04am |
![]() |
@MarcJacksonLA $NBIX Wedbush Analysts Increase Earnings Estimates for Neurocrine Biosciences | https://t.co/NKb5pRLCDo https://t.co/RPSY5Smjqe April 13th 2021, 3:04pm |
![]() |
@intercooleronli Contrasting Kodiak Sciences $KOD and Neurocrine Biosciences $NBIX https://t.co/NHHZN0jfhY #investingnews April 13th 2021, 12:04am |
![]() |
@TradeWithAlerts Large Print $NBIX Size: 264694 Price: 92.79 Time: 1600 Amount: $24,560,956.26 April 12th 2021, 8:04pm |
![]() |
@InsiderForms $NBIX JANUS Henderson GROUP PLC has filed Form SC 13G/A with SEC. Reporting 10.0% Ownership. Try Insider Forms mob… https://t.co/V11Vdh70Hd April 12th 2021, 6:04pm |
![]() |
@FlashAlert_me $NBIX [15s. delayed] filed form SC 13G/A on April 12, 14:46:52 https://t.co/PhoZvmBNyV April 12th 2021, 6:04pm |
![]() |
@mediasentiment $NBIX new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 451 April 12th 2021, 5:04pm |
![]() |
@mediasentiment $NBIX new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 450 April 12th 2021, 5:04pm |
![]() |
@stockhoot $NBIX Wedbush Maintains to Outperform : PT $112.00 https://t.co/Qvzqpeuyl2 April 12th 2021, 12:04pm |
![]() |
@Biotech2k1 @TerribleInvest3 I haven't followed in a long time, but I like $NBIX. April 11th 2021, 3:04pm |
![]() |
@TerribleInvest3 @Biotech2k1 Thanks for the update! ? On another note, would be interesting to hear if you an opinion on $NBIX April 11th 2021, 3:04pm |
![]() |
@newsfilterio Form DEF 14A (other definitive proxy statements) filed with the SEC $NBIX https://t.co/0x581rjKkS April 10th 2021, 3:04am |
![]() |
@newsfilterio Form DEFA14A (additional definitive proxy soliciting materials and rule 14(a)(12) material) filed with the SEC $NBIX https://t.co/PnBxZ3KRXK April 10th 2021, 3:04am |
![]() |
@Allstocknews $NBIX New Form DEFA14A for Neurocrine Biosciences, Inc. From our Stock News Alerts App April 10th 2021, 12:04am |
![]() |
@Allstocknews $NBIX New Form DEF 14A for Neurocrine Biosciences, Inc. From our Stock News Alerts App April 10th 2021, 12:04am |
![]() |
@ExecPayOrg Neurocrine Biosciences CEO Kevin Gorman's 2020 pay jumps 47% to $14M https://t.co/52WbidjUtJ $NBIX #execpay April 9th 2021, 9:04pm |
![]() |
@fintel_io $NBIX / Neurocrine Biosciences files form DEF 14A https://t.co/zFgofVxyvg April 9th 2021, 9:04pm |
![]() |
@KingsSaddle $NBIX Neurocrine Biosciences to Present Data from its Neurology Portfolio at the American Academy of Neurology's 73… https://t.co/wx4sVaDdok April 8th 2021, 10:04pm |
![]() |
@MarcJacksonLA $NBIX Neurocrine Biosciences To Present At American College of Neurology Meeting https://t.co/vjUauDMmml April 8th 2021, 8:04pm |
![]() |
@Allstocknews $NBIX Neurocrine Biosciences to Present Data from its Neurology Portfolio at the American Academy of Neurolog From our Stock News Alerts App April 8th 2021, 8:04pm |
![]() |
@StckPro $NBIX NEW ARTICLE : Neurocrine Biosciences to Present Data from its Neurology Portfolio at the American Academy of… https://t.co/42E36rvbRh April 8th 2021, 8:04pm |
![]() |
@otcdynamics $NBIX Neurocrine Biosciences to Present Data from its Neurology Portfolio at the American Academy of Neurology’s 73… https://t.co/3AmJYueo3m April 8th 2021, 8:04pm |
![]() |
@stock_titan $NBIX Neurocrine Biosciences to Present Data from its Neurology Portfolio at the American Academy of Neurology's 73… https://t.co/jmhW7odS7G April 8th 2021, 8:04pm |
![]() |
@sbwcws Neurocrine treatment of EECSWS granted FDA orphan designation $NBIX April 8th 2021, 7:04pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2021. All rights reserved.